| Website | galil-medical.com |
| Category | BioTech |
| Phone | 877.510.7757 |
| Employees | |
| Founded | 1996 |
| Description | Medical device company |
| TOTAL | $52M |
| VENTURE FUNDING TOTAL | $52M |
| Venture Round, 12/06 Thomas, McNerney & Partners The Vertical Group Investor Growth Capital | $52M |
Galil Medical is leading a new era of minimally invasive cryotherapy solutions that enhance patient quality of life. Galil Medical’s technology involves freezing and ablating diseased tissue in a technique referred to as cryotherapy, also referred to as cryoablation and cryosurgery. Galil Medical cryotherapy systems use compressed Argon gas to produce extremely low temperatures. As the gas passes through the cryoablation needle, the tip of the needle is cooled, forming an iceball, which engulfs the tumor and destroys the tissue. A variety of needle types is available to sculpt a freeze zone conformed to the tumor size and shape. Galil Medical cryosurgical systems precisely deliver sub-zero temperatures to target tissue with the aid of patented 17-gauge cryoablation needles and high-resolution imaging for the cryosurgical ablation of benign and cancerous tumors. Cryotherapy ablation has been widely used for prostate cancer treatment and kidney cancer treatment. New ablation treatments for various other tumors are being developed in the Women’s Health and Interventional Radiology markets.
